Please login to the form below
Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
Evenity back on track with FDA panel blessing in osteoporosis
US drugs regulator first rejected the drug due to cardiovascular concerns
NICE gives Lilly’s Verzenios chance to compete with rivals
Breast cancer drug also being appraised in novel combination
J&J’s Erleada cleared for early prostate cancer in Europe
Signals competiton for Xtandi
China approves Ironwood Pharma’s IBS treatment
Coincides with AZ's Mark Mallon taking over as CEO
Articles
-
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?Healthcare leaders in the European Union should begin preparing for a breakthrough now
-
The UK’s new five-year pricing agreementPharma has agreed to capped growth again - in exchange for uptake promises
-
Launch excellence: beyond the six-month mantraWhile the first six months are important, the prior 36 months are even more so.
-
Escaping the spin cycle of sub-optimal launch -
Relearning launch: Four key dynamics for pharma launches in 2019Syneos Health examines some of the key trends shaping industry launches in 2019 and beyond
Pharmaceutical Market Europe - January 2019
Just a few years into the New Year, the $74bn acquisition of Celgene by BMS has woken us all up from our post-festive slump with a bang. The merger is the fourth biggest ever, and could spark more multi-billion dollar M&A deals over the next 12 months.
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor - Iona Everson
Have your say...
Subscribe
'Nothing about us without us'
Why patient engagement is essential throughout the entire product life cycle
Featured jobs
-
Medical Writer
-
Salary TBC
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
-
Senior Account Manager
-
Competitive Salary Offered
-
Account Director, Medical Education
-
Salary TBC
-
Account Director
-
Competitive Salary Offered
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Associate Director
-
£75, 000-90, 000
- Global Business Development Director – Health Education
-
excellent commission
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Account Manager / Account Director
-
Competative
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Business Director
-
Competitive Salary Offered
Subscribe to our email news alerts
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
- NICE gives Lilly’s Verzenios chance to compete with rivals
- J&J’s Erleada cleared for early prostate cancer in Europe
- New faces at Lucid, 90Ten and Page & Page
PMHub
VCCP Health
We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
